Literature DB >> 8849672

Epidermal growth factor receptor in adult human dorsal root ganglia.

J J Huerta1, R Diaz-Trelles, F J Naves, M M Llamosas, M E Del Valle, J A Vega.   

Abstract

Transforming growth factor-alpha (TGFalpha) enhances neuronal survival and neurite outgrowth in cultured dorsal root ganglia (DRG) sensory neurons. It binds a membrane protein, denominated epidermal growth factor receptor (EGFr). EGFr has been localized in developing and adult human DRG. However, it remains to be elucidated whether all DRG neurons express EGFr or whether differences exist among neuronal subtypes. This study was undertaken to investigate these topics in adult human DRG using immunoblotting, and combined immunohistochemistry and image analysis techniques. A mouse monoclonal antibody (clone F4) mapping within the intracytoplasmic domain of EGFr was used. Immunoblotting revealed two main proteins with estimated molecular masses of approximately/equal to 65 kDa and 170 kDa, and thus consistent with the full-length EGFr. Additional protein bands were also encountered. Light immunohistochemistry revealed specific immunoreactivity (IR) for EGFr-like proteins in most (86%) primary sensory neurons, the intensity of immunostaining being stronger in the small- and intermediate-sized ones. Furthermore, EGFr-like IR was also observed in the satellite glial cells of the ganglia as well as in the intraganglionic and dorsal root Schwann cells. Taken together, our findings demonstrate that EGFr, and other related proteins containing the epitope labeled with the antibody F4, are responsible for the EGFr IR reported in DRG. Furthermore, we demonstrated heterogeneity in the expression of EGFr-like IR in adult human primary sensory neurons, which suggests different responsiveness to their ligands.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8849672     DOI: 10.1007/bf00187136

Source DB:  PubMed          Journal:  Anat Embryol (Berl)        ISSN: 0340-2061


  16 in total

1.  Spatiotemporal increases in epidermal growth factor receptors following peripheral nerve injury.

Authors:  J G Toma; S Pareek; P Barker; T C Mathew; R A Murphy; A Acheson; F D Miller
Journal:  J Neurosci       Date:  1992-07       Impact factor: 6.167

2.  Immunohistochemical localization of S-100 protein subunits (alpha and beta) in dorsal root ganglia of the rat.

Authors:  J A Vega; M E del Valle-Soto; B Calzada; J C Alvarez-Mendez
Journal:  Cell Mol Biol       Date:  1991       Impact factor: 1.770

Review 3.  Receptors for epidermal growth factor and other polypeptide mitogens.

Authors:  G Carpenter
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

Review 4.  Biosynthesis and metabolic degradation of receptors for epidermal growth factor.

Authors:  A M Soderquist; G Carpenter
Journal:  J Membr Biol       Date:  1986       Impact factor: 1.843

5.  Localization of immunoreactive epidermal growth factor receptors in human nervous system.

Authors:  M H Werner; L B Nanney; C M Stoscheck; L E King
Journal:  J Histochem Cytochem       Date:  1988-01       Impact factor: 2.479

6.  Epidermal growth factor-induced truncation of the epidermal growth factor receptor.

Authors:  S J Decker
Journal:  J Biol Chem       Date:  1989-10-25       Impact factor: 5.157

7.  Expression of beta-amyloid precursor protein (APP) in human dorsal root ganglia.

Authors:  F J Naves; B Calzada; A Cabal; V Alonso-Cortina; M E del Valle; M T Fernandez-Sanchez; J A Vega
Journal:  Neurosci Lett       Date:  1994-11-07       Impact factor: 3.046

Review 8.  Role of neurotrophins in mouse neuronal development.

Authors:  R Klein
Journal:  FASEB J       Date:  1994-07       Impact factor: 5.191

9.  Epidermal growth factor and its receptor in the developing human nervous system.

Authors:  E Birecree; L E King; L B Nanney
Journal:  Brain Res Dev Brain Res       Date:  1991-06-21

10.  Immunoreactivity for phosphorylated 200-kDa neurofilament subunit is heterogeneously expressed in human sympathetic and primary sensory neurons.

Authors:  J A Vega; J M Humara; F J Naves; I Esteban; M E Del Valle
Journal:  Anat Embryol (Berl)       Date:  1994-11
View more
  8 in total

Review 1.  Roles of transforming growth factor-alpha and related molecules in the nervous system.

Authors:  C J Xian; X F Zhou
Journal:  Mol Neurobiol       Date:  1999 Oct-Dec       Impact factor: 5.590

Review 2.  Modulation of Pathological Pain by Epidermal Growth Factor Receptor.

Authors:  Jazlyn P Borges; Katrina Mekhail; Gregory D Fairn; Costin N Antonescu; Benjamin E Steinberg
Journal:  Front Pharmacol       Date:  2021-05-12       Impact factor: 5.810

3.  Quantitative automated microscopy (QuAM) elucidates growth factor specific signalling in pain sensitization.

Authors:  Christine Andres; Sonja Meyer; Olayinka A Dina; Jon D Levine; Tim Hucho
Journal:  Mol Pain       Date:  2010-12-27       Impact factor: 3.395

4.  A disintegrin and metalloproteinase domain 17-epidermal growth factor receptor signaling contributes to oral cancer pain.

Authors:  Nicole N Scheff; Yi Ye; Zachary R Conley; Jen Wui Quan; Yat Vong Ronald Lam; Richard Klares; Kamalpreet Singh; Brian L Schmidt; Bradley E Aouizerat
Journal:  Pain       Date:  2020-10       Impact factor: 7.926

5.  The upregulation of EGFR in the dorsal root ganglion contributes to chronic compression of dorsal root ganglions-induced neuropathic pain in rats.

Authors:  Shuo Wang; Siyi Liu; Linping Xu; Xuan Zhu; Wanyuan Liu; Lixia Tian; Yu Chen; Yuying Wang; Borra V Padma Nagendra; Shushan Jia; Lingli Liang; Fu-Quan Huo
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

6.  EGFR Signaling Causes Morphine Tolerance and Mechanical Sensitization in Rats.

Authors:  Stephanie Puig; Courtney L Donica; Howard B Gutstein
Journal:  eNeuro       Date:  2020-04-06

Review 7.  Role of EGFR in the Nervous System.

Authors:  Roberta Romano; Cecilia Bucci
Journal:  Cells       Date:  2020-08-12       Impact factor: 6.600

8.  Breast cancer induced nociceptor aberrant growth and collateral sensory axonal branching.

Authors:  Matt Austin; Laura Elliott; Niovi Nicolaou; Anna Grabowska; Richard P Hulse
Journal:  Oncotarget       Date:  2017-09-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.